New Clinical Trial Partners to Expand Laboratory Sciences Clinical Sample Analysis Groups - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

New Clinical Trial Partners to Expand Laboratory Sciences Clinical Sample Analysis Groups



Charles River has established partnerships with Target Health Inc. and Theorem Clinical Research Inc. allow nonclinical testing programs performed by Charles River in bioanalysis, immunogenicity, and immunology to transition to support clinical trials.

Charles River develops and validates assays in support of nonclinical programs. Many of these assays can be transferred and validated for human matrix and subsequently used for analyzing clinical samples.

In a statement, the Charles River reports that these new relationships will allow company scientists to manage clinical sample analysis using defined processes and procedures to improve customer satisfaction.

http://www.criver.com

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here